联影医疗 reported revenue of ¥7.05B for the period ended 2026-06-30, +17.2% year on year. Net income was ¥0.89B, a 12.6% net margin on a 47.2% gross margin. The largest revenue line is 销售医学影像诊断设备及放射治疗设备 at 83% of the total. Free cash flow for the period was ¥0.16B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥7.05B | +17.2% |
| Gross profit | ¥3.33B | — |
| Operating income | ¥1.05B | — |
| Net income | ¥0.89B | -10.0% |
| Gross margin | 47.2% | Net margin 12.6% |
| Revenue Q/Q | +42.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 销售医学影像诊断设备及放射治疗设备 | ¥5.85B | 83.0% |
| 提供维修收入 | ¥0.98B | 13.9% |
| 其他(补充) | ¥0.21B | 2.9% |
| 软件收入 | ¥0.01B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.72B | 52.8% |
| R&D | ¥1.01B | 14.3% |
| SG&A | ¥1.36B | 19.2% |
| Tax & other | ¥0.16B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥34.44B |
| Total liabilities | ¥12.41B |
| Shareholders' equity | ¥22.02B |
| Equity / assets | 63.9% |
| Operating cash flow | ¥0.72B |
| Capital expenditure | ¥0.55B |
| Free cash flow | ¥0.16B |
| Cash conversion (OCF / net income) | -27% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
大全能源 ・ 华润微 ・ 阿特斯 ・ 百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies